Skip to contentR
Reflect Scientific, Inc.
R
RSCFReflect Scientific, Inc. Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$478.87K$478.87Kderived−42.2% vs Q4 2021 Net Income-$61.31K-$61.31KderivedN/M vs Q4 2021 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Reflect Scientific, Inc. · CIK 1103090 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$209,040−63.1% Operating Incomederived-$61,312N/M Operating Cash Flowderived$57,221−82.7% Margins · derivedGross margin43.7%−24.7 pt vs Q4 2021
Operating margin-12.8%−56.3 pt vs Q4 2021
Net margin-12.8%−56.3 pt vs Q4 2021
ended Dec 31, 2022 · filed Mar 31, 2023 · 90 d after period end